DFDA

Anticoagulation (e.g., Rivaroxaban)

Treatment for Vascular Intestinal Disorders

Typical Dosage: Rivaroxaban 20mg daily

Effectiveness
80%
Safety Score
55%
Clinical Trials
150
Participants
30K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
Rivaroxaban 20mg daily
Time to Effect
Hours-days
Treatment Duration
3-6 months to lifetime
Evidence Quality
HIGH
Number Needed to Harm (NNH)
200(Treat 200 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$600
Monitoring:$200
Side Effect Mgmt:$700
Total Annual:$1,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$40,000/QALY
QALYs Gained
1.8
Outcome-Based Costs
Cost per Responder
$1,875
Comparison vs Warfarin
Cost Difference
+$400/year
More expensive
QALY Difference
+0.10 QALYs
Better outcomes
Dominance
No dominance
Anticoagulation (e.g., Rivaroxaban) Outcomes

for Vascular Intestinal Disorders

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+80%
Common Side Effects
Bleeding (major)
+2%
Bleeding (minor)
+15%

Sources:

nih.gov
unich.it
dntb.gov.ua

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov